Request Trial
6 October 2026NewsCareersSarah Speight

Latham adds ‘exceptional’ ITC expert and 5th trial lawyer in a year

The new partner advises technology and life sciences companies in Section 337 investigations and related patent disputes, drawing on extensive private practice and government experience.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Fish & Richardson nets patent litigator to grow European practice
5 October 2026   Based in Munich, Germany, the new principal—who brings SEP licensing and trade secret expertise—will help grow the firm’s cross-border capabilities across Europe.
Careers
Clifford Chance recruits new head of Asia-Pac
29 September 2026   As partner and head of IP for the region, the Hong Kong-based hire brings extensive experience advising on the IP aspects of complex corporate transactions and investments.
Careers
Conley Rose welcomes back former employee with legal and business nous
28 September 2026   The returning shareholder’s work spans the patent lifecycle and includes computerised business methods, polymer compositions, and small molecules.


Editor's picks

Inside the deal boom: LSIPR’s five-part M&A series—all in one place
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

Editor's picks

Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026
Biotech
Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win
1 September 2026
Regulation & Industry
The buyers' wishlist: What makes a life sciences deal stack up?
25 August 2026
MedTech
Abbott fends off Chinese rival’s patent challenge at UPC
18 August 2026
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026
Regulation & Industry
Buying the brains: Why is Big Pharma shopping for innovation?
27 July 2026

More features

Roche, Marques counsel: The fight against ‘deadly’ counterfeits is a race for the newest and best tech
Fish & Richardson nets patent litigator to grow European practice
What's AI best at? In-house teams are still learning
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?
Lilly loses Fed Circ rehearing bid, sparking enablement questions
Westlaw publisher scores landmark AI copyright win in US appeals court
Scientist and Chinese biotech targeted by Beam in secrets suit